Dulabh Monga
Overview
Explore the profile of Dulabh Monga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tayshetye P, Miller K, Monga D, Brem C, Silverman J, Finley G
Front Med (Lausanne)
. 2020 Aug;
7:314.
PMID: 32760731
Many genomic alterations have been identified that are critical to the malignant phenotype. Some of these, termed "driver mutations," are critical for tumor proliferation and progression. The landscape of targeted...
12.
Wegner R, Verma V, Hasan S, Schiffman S, Thakkar S, Horne Z, et al.
J Gastrointest Oncol
. 2020 Jan;
10(6):1080-1093.
PMID: 31949925
Background: The only potentially curative approach for pancreatic cancer is surgical resection, but this technically challenging procedure carries risks for postoperative morbidities and mortality. This study of a large, contemporary...
13.
Jayakrishnan T, Pandya D, Monga D
J Gastrointest Cancer
. 2019 Dec;
51(2):658-662.
PMID: 31811471
No abstract available.
14.
Wegner R, Abel S, Monga D, Raj M, Finley G, Nosik S, et al.
Ann Surg Oncol
. 2019 Nov;
27(3):825-832.
PMID: 31720934
Background: Adjuvant radiation is generally not recommended for colon cancer but may be considered in certain clinical scenarios [advanced local disease (pT4) and/or positive margins]. Guidelines in this area are...
15.
Syed A, Carleton N, Horne Z, Dhawan A, Bedi G, Kochhar G, et al.
J Gastrointest Cancer
. 2019 Oct;
51(3):836-843.
PMID: 31605289
Purpose: Despite advances in various treatment modalities, surgical resection for pancreatic ductal adenocarcinoma (PDA) remains the only curative treatment. Data remains limited regarding survival rates for resectable PDA when managed...
16.
Khattab A, Patruni S, Abel S, Hasan S, Ludmir E, Finley G, et al.
J Gastrointest Oncol
. 2019 Oct;
10(5):918-927.
PMID: 31602330
Background: Response of pancreatic adenocarcinoma to neoadjuvant chemotherapy (nCT) or chemoradiotherapy (nCRT) may be associated with prognosis, but long-term outcomes based on response to neoadjuvant therapy have not been well...
17.
White R, Hasan S, Monga D, Finley G, Islam M, Schiffman S, et al.
Pancreas
. 2019 Aug;
48(8):1086-1091.
PMID: 31404024
Objectives: The appropriate timing of chemotherapy following surgery for resectable pancreatic adenocarcinoma is controversial. Using the National Cancer Database we evaluated time to initiation of chemotherapy postresection and correlated with...
18.
Wegner R, White R, Hasan S, Raj M, Monga D, Finley G, et al.
Cancer Med
. 2019 Jun;
8(8):3855-3863.
PMID: 31173487
Importance: Primary Adenocarcinoma of the anus is a rare disease with a poor prognosis and thus tends to have a more aggressive treatment algorithm, typically involving a surgical approach. Prior...
19.
Wegner R, Abel S, Hasan S, White R, Raj M, Monga D, et al.
Am J Clin Oncol
. 2019 May;
42(6):519-526.
PMID: 31136369
Background: Anal canal squamous cell carcinoma (SCC) is managed definitively with chemoradiation, reserving surgery for salvage. The dosage of radiation has varied from 30 Gy to in excess of 60 ...
20.
Renz P, Wegner R, Hasan S, Brookover R, Finley G, Monga D, et al.
Clin Colorectal Cancer
. 2019 Mar;
18(2):e237-e243.
PMID: 30905549
Background: With advances in systemic therapies, the role of primary tumor resection may be of increased importance in patients with metastatic rectal cancer. The role of combining pelvic radiotherapy with...